Literature DB >> 33067861

Seasonal flu and COVID-19 recommendations for children, adolescents and young adults with diabetes.

Andrea E Scaramuzza1, Ivana Rabbone2, Claudio Maffeis3, Riccardo Schiaffini4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33067861      PMCID: PMC7645934          DOI: 10.1111/dme.14427

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.213


× No keyword cloud information.
COVID‐19 is still a health problem and it is expected to grow in the coming weeks, especially after the school opens in mid‐September. Seasonal flu usually appears in mid‐October/November and has symptoms overlapping with COVID‐19. For these reasons the Italian Society for Pediatric Endocrinology and Diabetes formulated the following recommendations. Type 1, type 2 and monogenic diabetes in children, adolescents and young adults do not have a higher risk of morbidity and mortality due to COVID‐1 and/or seasonal flu. However, the glycemic imbalance due to disease itself suggests taking all possible preventive measure to minimize contagion. , Seasonal flu (influenza) vaccination is recommended in all children, adolescents and young adults, aged 6 months to 18 years (25years), regardless of their health status, if they have type 1, type 2 or monogenic diabetes. In the meantime we are waiting for an effective and safe vaccine against SARS/CoV/2, it is recommended to maintain active safeguards measures, such as spacing, face mask and adequate hygiene and sanitation. If you have a fever >37,5°C (99,5°F) for 2 or more days, nasopharyngeal swab is recommended. If COVID‐19 negative and otherwise advised by your pediatrician/family doctor or diabetes team, use only paracetamol or antipyretics. If COVID‐19 positive, oral dexamethasone may be useful in pediatric patients with respiratory disease only for those requiring mechanical ventilation. The use of dexamethasone is generally not recommended for pediatric patients who require only low levels of oxygen support (i.e., nasal cannula only). In that case, tight glycemic control is highly recommended. Tight glycemic control is recommended and, in any case, do not interrupt insulin administration via subcutaneous insulin infusion or multiple daily injections. Continuous glucose monitoring, real time or intermittently scanning is recommended whenever possible. If in hyperglycemia, especially if ketonemia >3 mg/dl (or ketonuria), and no measures work to keep blood glucose in range (change of the infusion set, correction boluses, etc.) consult the emergency room. In case of overwhelming vomiting, call the emergency room. These recommendations are based on the authors’ personal experience and a review of the scant literature on the subject. The goal is to distinguish the symptoms (fever, cough, and sore throat) due either to seasonal flu or COVID‐19. From our experience, both seasonal flu and COVID‐19 in children and in adolescents with diabetes, usually heal quite quickly, being completely asymptomatic or with mild to moderate symptoms, requiring only rest, hydration and anti‐pyretic drugs (paracetamol and/or ibuprofen) . In conclusion, not all fever and cough, especially in pediatrics, will be COVID‐19, and the only effective mean to distinguish between the two diseases will be nasopharyngeal swab. Supplementary Material Click here for additional data file.
  4 in total

Review 1.  Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia.

Authors:  Giuseppe d'Annunzio; Claudio Maffeis; Valentino Cherubini; Ivana Rabbone; Andrea Scaramuzza; Riccardo Schiaffini; Nicola Minuto; Gianluca Piccolo; Mohamad Maghnie
Journal:  Diabetes Res Clin Pract       Date:  2020-08-20       Impact factor: 5.602

2.  COVID-19 outbreak and pediatric diabetes: Perceptions of health care professionals worldwide.

Authors:  Nancy Samir Elbarbary; Tiago Jeronimo Dos Santos; Carine de Beaufort; Juliana Chizo Agwu; Luis Eduardo Calliari; Andrea Enzo Scaramuzza
Journal:  Pediatr Diabetes       Date:  2020-08-17       Impact factor: 3.409

Review 3.  A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children.

Authors:  Andi L Shane; Alice I Sato; Carol Kao; Felice C Adler-Shohet; Surabhi B Vora; Jeffery J Auletta; Sharon Nachman; Vanessa N Raabe; Kengo Inagaki; Ibukunoluwa C Akinboyo; Charles Woods; Abdulsalam O Alsulami; Mundeep K Kainth; Roberto Parulan Santos; Claudia M Espinosa; Julianne E Burns; Coleen K Cunningham; Samuel R Dominguez; Beatriz Larru Martinez; Frank Zhu; Jonathan Crews; Taito Kitano; Lisa Saiman; Karen Kotloff
Journal:  J Pediatric Infect Dis Soc       Date:  2020-11-10       Impact factor: 3.164

Review 4.  The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review.

Authors:  Rajat Bhattacharyya; Prasad Iyer; Ghee Chee Phua; Jan Hau Lee
Journal:  Pulm Ther       Date:  2020-08-25
  4 in total
  1 in total

1.  The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey.

Authors:  Nancy Samir Elbarbary; Tiago Jeronimo Dos Santos; Carine de Beaufort; Esko Wiltshire; Aman Pulungan; Andrea Enzo Scaramuzza
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-05       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.